SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-016832
Filing Date
2017-01-24
Accepted
2017-01-24 17:07:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A | AMENDMENT NO. 11 d302550dsc13ga.htm SC 13G/A 35371
  Complete submission text file 0001193125-17-016832.txt   36589
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Subject) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80200 | Film No.: 17544379
SIC: 2834 Pharmaceutical Preparations

Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
BELANOFF JOSEPH K (Filed by) CIK: 0001286199 (see all company filings)

Type: SC 13G/A